KRAS and colorectal carcinoma: A study of 97 primary CRC cases has shown that CIMP1 tumors are often microsatellite instable (80%) and have high BRAF mutations (53%), whereas CIMP2 tumors have very high KRAS mutations (92%), but rarely have MSI or BRAF or TP53 mutations [20].